Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqCM - Delayed Quote USD

Windtree Therapeutics, Inc. (WINT)

Compare
1.2000
-0.0600
(-4.76%)
At close: April 1 at 4:00:01 PM EDT
1.2200
+0.02
+(1.67%)
After hours: April 1 at 7:56:39 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
25,557
17,539
21,889
32,260
30,317
Operating Income
-25,557
-17,539
-21,889
-32,260
-30,317
Net Non Operating Interest Income Expense
-63
275
56
-23
-3
Other Income Expense
15,983
-3,027
-18,742
-45,340
-2,246
Pretax Income
-9,637
-20,291
-40,575
-77,623
-32,566
Tax Provision
71
--
-1,367
-9,987
--
Net Income Common Stockholders
-10,709
-20,291
-39,208
-67,636
-32,566
Diluted NI Available to Com Stockholders
-10,709
-20,291
-39,208
-67,636
-32,566
Basic EPS
-22.01
-94.32
-1.12k
-2.46k
-1.87k
Diluted EPS
-22.01
-94.32
-1.12k
-2.46k
-1.87k
Basic Average Shares
557.3330
215.3330
35
27.5110
17.3930
Diluted Average Shares
557.3330
215.3330
35
27.5110
17.3930
Total Operating Income as Reported
-25,557
-20,597
-41,333
-77,280
-30,317
Total Expenses
25,557
17,539
21,889
32,260
30,317
Net Income from Continuing & Discontinued Operation
-9,708
-20,291
-39,208
-67,636
-32,566
Normalized Income
-22,946.0300
-17,233
-21,095.4984
-28,408.2876
-32,566
Interest Income
123
325
109
91
122
Interest Expense
186
50
53
114
125
Net Interest Income
-63
275
56
-23
-3
EBIT
-9,451
-20,241
-40,522
-77,509
-32,441
EBITDA
-9,361
-20,159
-39,989
-77,317
-32,273
Reconciled Depreciation
90
82
533
192
168
Net Income from Continuing Operation Net Minority Interest
-9,708
-20,291
-39,208
-67,636
-32,566
Total Unusual Items Excluding Goodwill
16,757
-3,058
-18,744
-45,020
--
Total Unusual Items
16,757
-3,058
-18,744
-45,020
--
Normalized EBITDA
-26,118
-17,101
-21,245
-32,297
-32,273
Tax Rate for Calcs
0.0002
--
0
0.0001
--
Tax Effect of Unusual Items
3,518.9700
--
-631.4984
-5,792.2876
--
12/31/2020 - 8/7/1995

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

IBO Impact BioMedical Inc.
0.8200
-5.75%
 
PSTV Plus Therapeutics, Inc.
1.0200
+7.36%
 
ADTX Aditxt, Inc.
4.5200
+0.78%
 
RNAZ TransCode Therapeutics, Inc.
0.5409
+9.27%
 
DRMA Dermata Therapeutics, Inc.
0.9997
-7.44%
 
EVFM Evofem Biosciences, Inc.
0.0090
+2.27%
 
BDRX Biodexa Pharmaceuticals Plc
1.2000
-9.09%
 
SNSE Sensei Biotherapeutics, Inc.
0.3450
-12.44%
 
OSRH OSR Holdings, Inc.
1.7200
-8.51%
 
CDT Conduit Pharmaceuticals Inc.
0.7221
-7.54%